Phase II clinical study of SH/TA-508, at ultrasound contrast agent: A dose-finding study of SH/TA-508 in color Doppler flow imaging in the kidney
Hirohíde Matsuo, H Sawada, D Totsuka, Srdjan Saso, Masanobu Yoshida, Takafumi Yura, Naoki Ito(National Center for Geriatrics and Gerontology), Kenji Abe(Nihon Pharmaceutical University), Akihiro Kawauchi(Shiga University of Medical Science), T Sugisaki, Yoshitaka Kasai, Yoichi Imai(Dokkyo Medical University), T Takamoto, Shimpei Nakatani(Erasmus MC), Yoshiyuki Hada, Norihiro Takahashi, Kumiko Kato(Mie University), Kana Miyatake, Fuminobu Ishikura(National Cerebral and Cardiovascular Center)
Unknown
January 1, 1995
Cited by 1
Related Papers
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Chronic Estrogen Supplementation Following Ovariectomy Improves the Emotional Stress-Induced Cardiovascular Responses by Indirect Action on the Nervous System and by Direct Action on the Heart
|Circulation Journal|2007|185
Isoliquiritigenin Inhibits the Growth of Prostate Cancer
|European Urology|2003|162
Catecholamines and Estrogen Are Involved in the Pathogenesis of Emotional Stress‐induced Acute Heart Attack
|Annals of the New York Academy of Sciences|2008|159
Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation
|American Journal of Physiology-Heart and Circulatory Physiology|2002|136